Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$531M |
| 2 |
Kinder Morgan
KMI
|
+$496M |
| 3 |
IBM
IBM
|
+$253M |
| 4 |
CA
CA, Inc.
CA
|
+$213M |
| 5 |
Estee Lauder
EL
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$381M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 4 |
Apple
AAPL
|
+$333M |
| 5 |
Johnson & Johnson
JNJ
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 13.85% |
| 3 | Healthcare | 13.68% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Actinium Pharmaceuticals
ATNM
$30.2M
| $467K | ﹤0.01% |
2,643
-48
| -2% | -$9.12K |
|
|
FXEN
3552
DELISTED
FX ENERGY INC
FXEN
| $467K | ﹤0.01% |
301,615
-9,633
| -3% | -$23.7K |
|
3553
Invesco International Dividend Achievers ETF
PID
$917M
| $463K | ﹤0.01% |
26,451
-1,011
| -4% | -$18.2K |
|
3554
AstroNova
ALOT
$227M
| $461K | ﹤0.01% |
27,904
+13,020
| +87% | +$182K |
|
3555
NanoViricides
NNVC
$34.7M
| $461K | ﹤0.01% |
8,481
-155
| -2% | -$10.3K |
|
3556
Sportsman's Warehouse
SPWH
$46.8M
| $461K | ﹤0.01% |
62,906
+27,202
| +76% | +$196K |
|
3557
C&F Financial
CFFI
$288M
| $460K | ﹤0.01% |
11,573
-589
| -5% | -$21.6K |
|
3558
MPLX
MPLX
$59.6B
| $458K | ﹤0.01% |
6,230
-27,726
| -82% | -$1.77M |
|
3559
VanEck Vietnam ETF
VNM
$506M
| $455K | ﹤0.01% |
23,685
+10,275
| +77% | +$212K |
|
|
HDNG
3560
DELISTED
Hardinge Inc
HDNG
| $455K | ﹤0.01% |
38,116
-6,890
| -15% | -$77.8K |
|
|
ANV
3561
DELISTED
Allied Nevada Gold Corp
ANV
| $455K | ﹤0.01% |
523,633
-11,979,932
| -96% | -$19.9M |
|
|
DRNA
3562
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $454K | ﹤0.01% |
27,588
+3,868
| +16% | +$44.6K |
|
3563
SIFCO Industries
SIF
$121M
| $452K | ﹤0.01% |
15,509
-790
| -5% | -$24.6K |
|
3564
WisdomTree International MidCap Dividend Fund
DIM
$169M
| $449K | ﹤0.01% |
8,078
-772
| -9% | -$43.2K |
|
|
SLI
3565
DELISTED
S L INDUSTRIES INC (DELAWARE)
SLI
| $448K | ﹤0.01% |
11,487
+6,472
| +129% | +$262K |
|
|
SYUT
3566
DELISTED
Synutra International, Inc.
SYUT
| $446K | ﹤0.01% |
73,352
+782
| +1% | +$4.28K |
|
|
MOBL
3567
DELISTED
MobileIron, Inc.
MOBL
| $446K | ﹤0.01% |
44,684
+18,093
| +68% | +$172K |
|
3568
MGP Ingredients
MGPI
$389M
| $444K | ﹤0.01% |
28,019
+11,021
| +65% | +$152K |
|
|
NWHM
3569
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $442K | ﹤0.01% |
30,515
+4,114
| +16% | +$58.4K |
|
3570
Safe Bulkers
SB
$781M
| $440K | ﹤0.01% |
112,478
-94,695
| -46% | -$476K |
|
3571
VanEck Pharmaceutical ETF
PPH
$991M
| $437K | ﹤0.01% |
6,800
| – | – |
|
3572
Gaia
GAIA
$33.3M
| $430K | ﹤0.01% |
60,329
-1,003
| -2% | -$7.28K |
|
3573
Century Communities
CCS
$2.04B
| $428K | ﹤0.01% |
+24,744
| New | +$422K |
|
3574
MidCap Financial Investment
MFIC
$811M
| $427K | ﹤0.01% |
19,136
+14,536
| +316% | +$348K |
|
|
FFKT
3575
DELISTED
Farmers Capital Bank Corp
FFKT
| $426K | ﹤0.01% |
18,336
-2,043
| -10% | -$46.7K |
|
Similar funds
Bank of New York Mellon's Q4 2014 Portfolio in Review
As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
- Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
- Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
- Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
- Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
- Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.
Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.